EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate

Michelle Y Meng iD, Luke W Paine, David Sagnat, Ivana Bello, Sophie Oldroyd, Farideh Javid iD, Matthew T Harper iD, James R F Hockley, Ewan St John Smith, Róisín M Owens, Laurent Alric, Etienne Buscail iD and 3 more

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17408 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025. Written by Michelle Y Meng and 14 co-authors. Institution: Department of Pharmacology, University of Cambridge, Cambridge, UK. Major MEDLINE topics: TRPV Cation Channels, Glutamic Acid, Colon, Adenosine Triphosphate. Cited 5 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: AstraZeneca, Engineering and Physical Sciences Research Council.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Abdominal pain is a leading cause of morbidity for people living with gastrointestinal disease. Whereas the transient receptor potential vanilloid 4 (TRPV4) ion channel has been implicated in the pathogenesis of abdominal pain, the relative paucity of TRPV4 expression in colon‐projecting sensory neurons suggests that non‐neuronal cells may contribute to TRPV4‐mediated nociceptor stimulation. Experimental Approach Changes in murine colonic afferent activity were examined using ex vivo electrophysiology in tissues with the gut mucosa present or removed. ATP and glutamate release were measured by bioluminescence assays from human colon organoid cultures and mouse colon. Dorsal root ganglion sensory neuron activity was evaluated by Ca 2+ imaging when cultured alone or co‐cultured with colonic mucosa. Key Results Bath application of TRPV4 agonist GSK1016790A elicited a robust increase in murine colonic afferent activity, which was abolished by removing the gut mucosa. GSK1016790A promoted ATP and glutamate release from human colon organoid cultures and mouse colon. Inhibition of ATP degradation in mouse colon enhanced the afferent response to GSK1016790A. Pretreatment with purinoceptor or glutamate receptor antagonists attenuated and abolished the response to GSK1016790A when given alone or in combination, respectively. Sensory neurons co‐cultured with colonic mucosal cells produced a marked increase in intracellular Ca 2+ to GSK1016790A compared with neurons cultured alone. Conclusion and Implications Our data indicate that mucosal release of ATP and glutamate is responsible for the stimulation of colonic afferents following TRPV4 activation. These findings highlight an opportunity to target the gut mucosa for the development of new visceral analgesics.

Subjects

MeSH terms (MEDLINE)

TRPV Cation ChannelsGlutamic AcidColonAdenosine TriphosphateIntestinal MucosaAnimalsHumansMiceMaleSulfonamidesMice, Inbred C57BLLeucineNeurons, AfferentFemale

Author keywords

ATPTRPV4colonic afferentsglutamateintestinal mucosavisceral hypersensitivity

Substances

TRPV Cation ChannelsGlutamic AcidAdenosine TriphosphateTrpv4 protein, mouseSulfonamidesN-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothi…TRPV4 protein, humanLeucine

Authors and institutions

  • Department of Pharmacology, University of Cambridge, Cambridge, UK.
  • IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
  • Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
  • Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
  • Internal Medicine Department of Digestive Disease, CHU Toulouse-Rangueil and Université de Toulouse, Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.

ORCID profiles: Michelle Y Meng, Farideh Javid, Matthew T Harper, Etienne Buscail, Nathalie Vergnolle, David C Bulmer

Funding

  • AstraZeneca
  • Engineering and Physical Sciences Research Council

Cite

APA

Meng, M. Y., Paine, L. W., Sagnat, D., Bello, I., Oldroyd, S., Javid, F., Harper, M. T., Hockley, J. R. F., St John Smith, E., Owens, R. M., Alric, L., Buscail, E., Welsh, F., Vergnolle, N., & Bulmer, D. C. (2025). TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate. British Journal of Pharmacology. https://doi.org/10.1111/bph.17408

Vancouver

Meng MY, Paine LW, Sagnat D, Bello I, Oldroyd S, Javid F, et al. TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate. British Journal of Pharmacology. 2025. doi:10.1111/bph.17408

BibTeX
@article{Meng2025,
  author = {Meng, Michelle Y and Paine, Luke W and Sagnat, David and Bello, Ivana and Oldroyd, Sophie and Javid, Farideh and Harper, Matthew T and Hockley, James R F and St John Smith, Ewan and Owens, Róisín M and Alric, Laurent and Buscail, Etienne and Welsh, Fraser and Vergnolle, Nathalie and Bulmer, David C},
  title = {TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17408}
}
Start for free →